A Screen Using iPSC-Derived Hepatocytes Reveals NAD(+) as a Potential Treatment for mtDNA Depletion Syndrome

Patients with mtDNA depletion syndrome 3 (MTDPS3) often die as children from liver failure caused by severe reduction in mtDNA content. The identification of treatments has been impeded by an inability to culture and manipulate MTDPS3 primary hepatocytes. Here we generated DGUOK-deficient hepatocyte...

Descripción completa

Detalles Bibliográficos
Autores principales: Jing, Ran, Corbett, James L., Cai, Jun, Beeson, Gyda C., Beeson, Craig C., Chan, Sherine S., Dimmock, David P., Lazcares, Lynn, Geurts, Aron M., Lemasters, John J., Duncan, Stephen A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289059/
https://www.ncbi.nlm.nih.gov/pubmed/30404003
http://dx.doi.org/10.1016/j.celrep.2018.10.036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289059/
https://www.ncbi.nlm.nih.gov/pubmed/30404003
http://dx.doi.org/10.1016/j.celrep.2018.10.036

Ejemplares similares